Publication | Closed Access

Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1

InflammationCytokineGraft-versus-host DiseaseAnti-inflammatoryAutoimmune DiseaseImmunologyChronic InflammationAutoimmunityCell TransplantationImmunotherapyMedicineCell BiologyInflammatory Cytokine Milieu